Kyto Technology And Life Science Inc (KBPH) Return on Assets ROA from the third quarter of 2022 to third quarter of 2021 and for the year 2022, Average High and Low, Fundamental Ratios from Dec 31 2021 to Dec 31 2020 - CSIMarket
CSIMarket
 


Kyto Technology And Life Science Inc   (KBPH)


Kyto Technology And Life Science Inc 's ROA from the third quarter of 2022 to the third quarter of 2021 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Kyto Technology And Life Science Inc 's ROA in the third quarter of 2022?
Kyto Technology And Life Science Inc achieved a return on average assets (ROA) of 15.58 % in its third quarter of 2022, this is above KBPH's average return on assets of -10.44%.
Kyto Technology And Life Science Inc assets over the 12 months ending in its third quarter of 2022 are valued at $7 million

Despite the company's net income deteriorating, Kyto Technology And Life Science Inc was able to improve its ROA compared to the second quarter of 2022.

However, within the Healthcare sector 116 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the second quarter of 2022 from 857 to 868.

What is ROA?



Return On Assets (Dec 31 2021)
III. Quarter
(Sep 30 2021)
II. Quarter
(Jun 30 2021)
I. Quarter
(Mar 31 2021)
IV. Quarter
(Dec 31 2020)
III. Quarter
Y / Y Total Assets Change -86.09 % 156.69 % 189.05 % 212.22 % 121.9 %
Y / Y Net Income Change - 213.11 % - - -
Net Income (TTM) in million 1 1 0 0 0
Return On Assets (TTM) 15.58 % 9.34 % 1.89 % 7.68 % -2.08 %
KBPH's Total Ranking # 868 # 857 # 2077 # 845 # 3075
Total Assets (TTM) in million 1 11 9 8 6
Seq. Total Assets Change -91.79 % 24.99 % 4.31 % 30.03 % 51.42 %
Seq. Net Income Change -67.86 % - - - -



Return On Assets Company Ranking
Within: No.
Industry # 54
Sector # 117
Overall # 851

Return On Assets Statistics
High Average Low
10.99 %
-10.44 %
-29.54 %
(Dec 31 2021)   (Mar 31 2020)





Financial Statements
Kyto Technology And Life Science Inc 's Assets $ 1 million KBPH's Balance sheet
Kyto Technology And Life Science Inc 's Income $ 0 million Quarterly KBPH's Income Statement
KBPH's Income by Division See KBPH's Income by Division



Annual Return On Assets (Mar 31 2021)
FY 2021
(Mar 31 2020)
FY 2020
(Mar 31 2019)
FY 2019

FY

FY
Y / Y Total Assets Change 212.22 % 69.51 % - - -
Total Assets in million 8 3 2 0 0
Y / Y Net Income Change - - - - -
Net Income in million 0 -1 0 0 0
Annual Return On Assets 5.07 % -28.65 % -14.45 % - -




Comment on KBPH's ROA in the fiscal year ending 2021
In the fiscal year 2021 ROA improved to 5.07 % compared to prior year, due to annual net income growth of % to $0.43 million, while value of Kyto Technology And Life Science Inc 's overall assets grew just by 212.22 % to $8.43 million, compared to $8.43 a year before.


More Return On Assets Ratios
KBPH's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
KBPH's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for KBPH's Competitors
Subscribers only: Roa for Kyto Technology And Life Science Inc 's Suppliers
Subscribers only: Return On Assets for KBPH's Customers

You may also want to know
KBPH's Roi KBPH's Inventory Turnover Ratio KBPH's Growth Rates KBPH's Dividend Comparisons
KBPH's Profitability Ratios KBPH's Asset Turnover Ratio KBPH's Dividend Growth
KBPH's Roe KBPH's Valuation Ratios KBPH's Financial Strength Ratios KBPH's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2021, within Healthcare Sector ROA
Carisma Therapeutics Inc   40.94 %
Innoviva Inc   39.97 %
Vir Biotechnology Inc   39.46 %
Halozyme Therapeutics Inc   37.62 %
Molecular Templates Inc   36.62 %
Semler Scientific inc   36.59 %
Regeneron Pharmaceuticals Inc   36.55 %
Iteos Therapeutics Inc   34.90 %
Inmode Ltd   34.50 %
Co diagnostics Inc   33.38 %
Quidelortho Corp  33.37 %
Retractable Technologies Inc  32.11 %
Biodelivery Sciences International Inc   31.63 %
Rennova Health Inc   31.59 %
Idexx Laboratories Inc  31.16 %
Check Cap Ltd  30.91 %
Biocept Inc   30.52 %
Integrated Biopharma Inc  28.34 %
Purple Biotech Ltd  26.31 %
Novo Nordisk A  25.66 %
Organogenesis Holdings Inc   25.50 %
Bio rad Laboratories Inc   25.43 %
Nrc Health  24.47 %
Mettler toledo International Inc   24.21 %
Genfit S a   23.87 %
Indaptus Therapeutics Inc   23.72 %
Incyte Corporation  22.72 %
Waters Corporation  22.12 %
Exelixis Inc   21.83 %
West Pharmaceutical Services Inc   21.82 %


Date modified: 2022-03-01T22:51:15+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.